AMBERLITE™ and DUOLITE™ Ion Exchange Resins
Proven Polymers That Provide Formulation Flexibility in Drug Delivery Applications
As an excipient, ion exchange resins have a long history, with the first use in pharmaceutical formulations reported in 1950. They are proven polymers providing formulation flexibility and offering a unique solution to formulation problems.
AMBERLITE™ and DUOLITE™ have shown to be safe and effective excipients and are used in many commercial drug formulations, throughout the world. AMBERLITE™ an cationic exchange and DUOLITE™ an ionic exchange resin are used in suspension formulations for controlled release and taste-masking in the geriatric and pediatric populations that offer improved patient compliance.
- Modified release
- Tablet disintegrant
- Solubility enhancement
- Drug stability
- Abuse deterrence
AMBERLITE™ and DUOLITE™ are trademarks of The Dow Chemical Company
Product Application Data
- AAPS 2017 - Investigation of Ion Exchange Resin Concentration, Particle Size and Process Temperature for Dextromethorphan HBr Complexation
- AAPS 2018 - Investigation of a Small Volume Dissolution Method to Simulate Mouth Cavity Condition for Taste-masking Evaluation of Dextromethorphan – Resin Complex